Variation in IL7R predisposes to sarcoid inflammation

Hofmann S, Franke A, Fischer A, Jacobs G, Nothnagel M, Gaede KI et al. Genome-wide association study identifies ANXA11 as a new susceptibility locus for sarcoidosis. Nat Genet 2008; 40: 1103–1106.

Iannuzzi MC, Iyengar SK, Gray-McGuire C, Elston RC, Baughman RP, Donohue JF et al. Genome-wide search for sarcoidosis susceptibility genes in African Americans. Genes Immun 2005; 6: 509–518.

Schurmann M, Reichel P, Muller-Myhsok B, Schlaak M, Muller-Quernheim J, Schwinger E . Results from a genome-wide search for predisposing genes in sarcoidosis. Am J Respir Crit Care Med 2001; 164: 840–846.

Valentonyte R, Hampe J, Huse K, Rosenstiel P, Albrecht M, Stenzel A et al. Sarcoidosis is associated with a truncating splice site mutation in BTNL2. Nat Genet 2005; 37: 357–364.

Grunewald J . Genetics of sarcoidosis. Curr Opin Pulm Med 2008; 14: 434–439.

Noguchi M, Nakamura Y, Russell SM, Ziegler SF, Tsang M, Cao X et al. Interleukin-2 receptor gamma chain: a functional component of the interleukin-7 receptor. Science 1993; 262: 1877–1880.

Kaech SM, Tan JT, Wherry EJ, Konieczny BT, Surh CD, Ahmed R . Selective expression of the interleukin 7 receptor identifies effector CD8 T cells that give rise to long-lived memory cells. Nat Immunol 2003; 4: 1191–1198.

Kallies A . Distinct regulation of effector and memory T-cell differentiation. Immunol Cell Biol 2008; 86: 325–332.

Sprent J, Cho JH, Boyman O, Surh CD . T cell homeostasis. Immunol Cell Biol 2008; 86: 312–319.

Li J, Huston G, Swain SL . IL-7 promotes the transition of CD4 effectors to persistent memory cells. J Exp Med 2003; 198: 1807–1815.

Fry TJ, Mackall CL . The many faces of IL-7: from lymphopoiesis to peripheral T cell maintenance. J Immunol 2005; 174: 6571–6576.

Liu YJ, Soumelis V, Watanabe N, Ito T, Wang YH, Malefyt RW et al. TSLP: an epithelial cell cytokine that regulates T cell differentiation by conditioning dendritic cell maturation. Annu Rev Immunol 2007; 25: 193–219.

Watanabe N, Hanabuchi S, Soumelis V, Yuan W, Ho S, de Waal MR et al. Human thymic stromal lymphopoietin promotes dendritic cell-mediated CD4+ T cell homeostatic expansion. Nat Immunol 2004; 5: 426–434.

Watanabe N, Wang YH, Lee HK, Ito T, Wang YH, Cao W et al. Hassall's corpuscles instruct dendritic cells to induce CD4+CD25+ regulatory T cells in human thymus. Nature 2005; 436: 1181–1185.

Rochman I, Watanabe N, Arima K, Liu YJ, Leonard WJ . Cutting edge: direct action of thymic stromal lymphopoietin on activated human CD4+ T cells. J Immunol 2007; 178: 6720–6724.

Ebers GC, Kukay K, Bulman DE, Sadovnick AD, Rice G, Anderson C et al. A full genome search in multiple sclerosis. Nat Genet 1996; 13: 472–476.

Kurz T, Hoffjan S, Hayes MG, Schneider D, Nicolae R, Heinzmann A et al. Fine mapping and positional candidate studies on chromosome 5p13 identify multiple asthma susceptibility loci. J Allergy Clin Immunol 2006; 118: 396–402.

Smyth DJ, Cooper JD, Bailey R, Field S, Burren O, Smink LJ et al. A genome-wide association study of nonsynonymous SNPs identifies a type 1 diabetes locus in the interferon-induced helicase (IFIH1) region. Nat Genet 2006; 38: 617–619.

Gregory SG, Schmidt S, Seth P, Oksenberg JR, Hart J, Prokop A et al. Interleukin 7 receptor alpha chain (IL7R) shows allelic and functional association with multiple sclerosis. Nat Genet 2007; 39: 1083–1091.

Palmer MJ, Mahajan VS, Trajman LC, Irvine DJ, Lauffenburger DA, Chen J . Interleukin-7 receptor signaling network: an integrated systems perspective. Cell Mol Immunol 2008; 5: 79–89.

Abdallah A, Sato H, Grutters JC, Veeraraghavan S, Lympany PA, Ruven HJ et al. Inhibitor kappa B-alpha (IkappaB-alpha) promoter polymorphisms in UK and Dutch sarcoidosis. Genes Immun 2003; 4: 450–454.

Amoli MM, Lopez-Agreda H, Suarez-Amor O, Martin J, Ollier WE, Gonzalez-Gay MA . Endothelial nitric oxide synthase polymorphisms in biopsy-proven erythema nodosum from a defined population. Clin Exp Rheumatol 2007; 25: 624–626.

Kruit A, Ruven HJ, Grutters JC, van den Bosch JM . Angiotensin-converting enzyme 2 (ACE2) haplotypes are associated with pulmonary disease phenotypes in sarcoidosis patients. Sarcoidosis Vasc Diffuse Lung Dis 2005; 22: 195–203.

Kruit A, Grutters JC, Ruven HJ, van Moorsel CH, Weiskirchen R, Mengsteab S et al. Transforming growth factor-beta gene polymorphisms in sarcoidosis patients with and without fibrosis. Chest 2006; 129: 1584–1591.

Spagnolo P, Renzoni EA, Wells AU, Sato H, Grutters JC, Sestini P et al. C-C chemokine receptor 2 and sarcoidosis: association with Lofgren's syndrome. Am J Respir Crit Care Med 2003; 168: 1162–1166.

Spagnolo P, Renzoni EA, Wells AU, Copley SJ, Desai SR, Sato H et al. C-C chemokine receptor 5 gene variants in relation to lung disease in sarcoidosis. Am J Respir Crit Care Med 2005; 172: 721–728.

Carlisle J, Evans W, Hajizadeh R, Nadaf M, Shepherd B, Ott RD et al. Multiple mycobacterium antigens induce interferon-gamma production from sarcoidosis peripheral blood mononuclear cells. Clin Exp Immunol 2007; 150: 460–468.

Taflin C, Miyara M, Nochy D, Valeyre D, Naccache JM, Altare F et al. FoxP3+ regulatory T cells suppress early stages of granuloma formation but have little impact on sarcoidosis lesions. Am J Pathol 2009; 174: 497–508.

Liu W, Putnam AL, Xu-Yu Z, Szot GL, Lee MR, Zhu S et al. CD127 expression inversely correlates with FoxP3 and suppressive function of human CD4+ T reg cells. J Exp Med 2006; 203: 1701–1711.

Bayer AL, Lee JY, de la BA, Surh CD, Malek TR . A function for IL-7R for CD4+CD25+Foxp3+ T regulatory cells. J Immunol 2008; 181: 225–234.

Fontenot JD, Rasmussen JP, Gavin MA, Rudensky AY . A function for interleukin 2 in Foxp3-expressing regulatory T cells. Nat Immunol 2005; 6: 1142–1151.

Mazzucchelli R, Hixon JA, Spolski R, Chen X, Li WQ, Hall VL et al. Development of regulatory T cells requires IL-7R{alpha} stimulation by IL-7 or TSLP. Blood 2008; 112: 3283–3292.

Soumelis V, Reche PA, Kanzler H, Yuan W, Edward G, Homey B et al. Human epithelial cells trigger dendritic cell mediated allergic inflammation by producing TSLP. Nat Immunol 2002; 3: 673–680.

Costabel U, Hunninghake GW . ATS/ERS/WASOG statement on sarcoidosis. Sarcoidosis Statement Committee. American Thoracic Society. European Respiratory Society. World Association for Sarcoidosis and Other Granulomatous Disorders. Eur Respir J 1999; 14: 735–737.

Hunninghake GW, Costabel U, Ando M, Baughman R, Cordier JF, du BR et al. ATS/ERS/WASOG statement on sarcoidosis. American Thoracic Society/European Respiratory Society/World Association of Sarcoidosis and other Granulomatous Disorders. Sarcoidosis Vasc Diffuse Lung Dis 1999; 16: 149–173.

Heron M, Slieker WA, Zanen P, van Lochem EG, Hooijkaas H, van den Bosch JM et al. Evaluation of CD103 as a cellular marker for the diagnosis of pulmonary sarcoidosis. Clin Immunol 2008; 126: 338–344.

Kruit A, Grutters JC, Gerritsen WB, Kos S, Wodzig WK, van den Bosch JM et al. ACE I/D-corrected Z-scores to identify normal and elevated ACE activity in sarcoidosis. Respir Med 2007; 101: 510–515.

de Bakker PI, Yelensky R, Pe'er I, Gabriel SB, Daly MJ, Altshuler D . Efficiency and power in genetic association studies. Nat Genet 2005; 37: 1217–1223.

Li J, Ji L . Adjusting multiple testing in multilocus analyses using the eigenvalues of a correlation matrix. Heredity 2005; 95: 221–227.

Barrett JC, Fry B, Maller J, Daly MJ . Haploview: analysis and visualization of LD and haplotype maps. Bioinformatics 2005; 21: 263–265.

Stephens M, Donnelly P . A comparison of bayesian methods for haplotype reconstruction from population genotype data. Am J Hum Genet 2003; 73: 1162–1169.